Kidney

Tag

Pages related to Kidney.

SURPASS-CVOT post hoc: broader cardiorenal outcomes favor tirzepatide vs dulaglutide

A post hoc analysis of SURPASS-CVOT expands the endpoint list beyond classic MACE. In patients with type 2 diabetes and established CVD, tirzepatide was associated with fewer composite cardiovascular + kidney events than dulaglutide, with more GI side effects.

news March 28, 2026

GLP‑1 drugs in type 1 diabetes: the safety signal gets sharper

A huge electronic health record analysis suggests GLP‑1 receptor agonists in type 1 diabetes may be linked to fewer major heart and kidney events without a clear increase in hospitalized DKA—a promising signal that still isn’t a randomized trial.

news March 19, 2026